V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160118 | 20061629 | 1.59 | 65.9 | Palliative (P) | 2017-12-12 | 2018-01-02 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100502496 |
| 20160121 | 20061630 | 1.67 | 70 | Neo-adjuvant (N) | 2018-02-11 | 2018-02-23 | ECX | 02 | N | ECX | 100097680 |
| 20160122 | 20061631 | 1.64 | 82.8 | Palliative (P) | 2020-01-17 | 2020-02-12 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101299052 |
| 20160123 | 20061632 | 1.55 | 54.3 | Adjuvant (A) | 2018-12-30 | 2019-01-20 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100490191 |
| 20160124 | 20061633 | 1.74 | 80 | Palliative (P) | 2018-03-09 | 2018-04-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101670585 |
| 20160126 | 20061634 | 1.81 | 104.5 | Adjuvant (A) | 2018-06-12 | 2018-06-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100408174 |
| 20160127 | 20061635 | 1.7 | 81 | Neo-adjuvant (N) | 2019-10-28 | 2019-11-12 | ECX | 2 | N | ECX | 101126072 |
| 20160128 | 20061636 | 1.75 | 59 | Palliative (P) | 2019-08-31 | 2019-09-05 | ECX | 02 | N | ECX | 100958404 |
| 20160129 | 20061637 | 1.67 | 91.6 | Adjuvant (A) | 2017-06-25 | 2017-07-09 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100780919 |
| 20160130 | 20061638 | 1.73 | 73.2 | Adjuvant (A) | 2016-06-11 | 2016-06-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100176947 |
| 20160132 | 20061639 | 1.7 | 60.5 | Palliative (P) | 2018-08-24 | 2018-09-07 | ECX | 2 | N | ECX | 101654909 |
| 20160138 | 20061640 | 1.83 | 104 | Palliative (P) | 2018-01-15 | 2018-02-07 | CAPECITABINE + GEMCITABINE | 01 | N | CAPECITABINE + GEMCITABINE | 101196901 |
| 20160139 | 20061641 | 1.91 | 51.2 | Adjuvant (A) | 2018-09-30 | 2018-09-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101691663 |
| 20160140 | 20061642 | 1.72 | 64 | Curative (C) | 2018-06-07 | 2018-06-12 | ECX | N | N | ECX | 101467174 |
| 20160142 | 20061643 | 1.71 | 81 | Adjuvant (A) | 2016-05-29 | 2016-05-29 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100758417 |
| 20160144 | 20061644 | 1.81 | 98.2 | Neo-adjuvant (N) | 2016-03-11 | 2016-03-11 | ECX | N | N | ECX | 100401958 |
| 20160145 | 20061645 | 1.72 | 52 | Neo-adjuvant (N) | 2018-11-09 | 2018-11-11 | ECX | 2 | N | ECX | 100453276 |
| 20160147 | 20061646 | 1.55 | 88 | Palliative (P) | 2017-10-28 | 2017-11-04 | Gemcitabine + Capecitabine | N | Y | ECX | 101832159 |
| 20160148 | 20061647 | null | null | Neo-adjuvant (N) | 2020-01-20 | 2020-01-31 | ECX | N | null | ECX | 100769323 |
| 20160149 | 20061648 | 1.85 | 71.7 | Curative (C) | 2019-07-21 | 2019-08-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100558077 |
| 20160150 | 20061649 | 1.66 | 61 | Neo-adjuvant (N) | 2018-02-12 | 2018-02-24 | ECX | 02 | N | ECX | 100836322 |
| 20160154 | 20061650 | 1.66 | 63.2 | Neo-adjuvant (N) | 2016-07-17 | 2016-08-03 | ECX | N | N | ECX | 100587930 |
| 20160155 | 20061651 | 1.77 | 98.4 | Adjuvant (A) | 2017-01-20 | 2017-02-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101139329 |
| 20160156 | 20061652 | 1.65 | 82.8 | Palliative (P) | 2018-10-05 | 2018-11-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101365718 |
| 20160157 | 20061653 | 1.52 | 63.4 | Adjuvant (A) | 2018-09-17 | 2018-09-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100175780 |
| 20160158 | 20061654 | 1.57 | 62.3 | Palliative (P) | 2016-08-04 | 2016-08-23 | ECX | N | N | ECX | 100461419 |
| 20160159 | 20061655 | 1.71 | 47 | Neo-adjuvant (N) | 2018-02-22 | 2018-02-22 | ECX | 02 | N | ECX | 101410205 |
| 20160160 | 20061656 | 1.58 | 65 | Neo-adjuvant (N) | null | 2019-02-20 | ECX | N | N | ECX | 100412173 |
| 20160161 | 20061657 | 1.8 | 78 | null | 2017-01-25 | 2017-02-02 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101658203 |
| 20160163 | 20061658 | 1.83 | 83.5 | Adjuvant (A) | 2016-07-15 | 2016-07-19 | ECX | N | N | ECX | 100847163 |
| 20160164 | 20061659 | 1.61 | 68 | Palliative (P) | 2016-04-24 | 2016-05-02 | ECX | N | N | ECX | 101302598 |
| 20160165 | 20061660 | 1.77 | 94.8 | Neo-adjuvant (N) | 2020-01-31 | 2020-02-02 | ECX | N | N | ECX | 101258626 |
| 20160166 | 20061661 | 1.85 | 52 | Adjuvant (A) | 2018-01-20 | 2018-02-02 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100765523 |
| 20160167 | 20061662 | 1.7 | 62 | Neo-adjuvant (N) | 2018-01-22 | 2018-01-31 | ECX | N | N | ECX | 100871972 |
| 20160172 | 20061663 | 1.88 | 100.5 | Neo-adjuvant (N) | 2017-02-07 | 2017-02-14 | ECX | 2 | N | ECX | 101304995 |
| 20160173 | 20061664 | 1.65 | 93 | Palliative (P) | 2016-08-01 | 2016-08-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100058438 |
| 20160174 | 20061665 | 1.79 | 61.5 | Palliative (P) | 2019-12-09 | 2019-12-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101332203 |
| 20160176 | 20061666 | null | 61 | Palliative (P) | 2016-11-22 | 2016-12-06 | ECX | N | null | ECX | 100107018 |
| 20160177 | 20061667 | 1.8 | 66.9 | Curative (C) | 2018-02-03 | 2018-02-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100874249 |
| 20160178 | 20061668 | 1.58 | null | Palliative (P) | 2016-11-19 | 2016-11-24 | ECX | 02 | N | ECX | 100128796 |
| 20160179 | 20061669 | 1.57 | 55.4 | Palliative (P) | 2018-05-28 | 2018-06-05 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101534268 |
| 20160180 | 20061670 | 1.65 | 56 | Palliative (P) | 2020-01-19 | 2020-02-03 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101081502 |
| 20160182 | 20061671 | 1.57 | 56 | Adjuvant (A) | 2018-06-28 | 2018-06-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101181204 |
| 20160183 | 20061672 | 1.57 | 67.9 | Palliative (P) | 2019-02-15 | 2019-02-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101062124 |
| 20160184 | 20061673 | 1.67 | 65 | Curative (C) | 2019-07-20 | 2019-07-20 | ECX | 02 | null | ECX | 100020987 |
| 20160185 | 20061674 | 1.63 | 95.7 | Palliative (P) | 2018-02-14 | 2018-02-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101292254 |
| 20160187 | 20061675 | 1.73 | 77.9 | Adjuvant (A) | 2016-03-08 | 2016-03-31 | ECX | N | N | ECX | 101032575 |
| 20160189 | 20061676 | 1.75 | 68 | Neo-adjuvant (N) | 2019-09-07 | 2019-09-14 | ECX | 02 | Y | ECX | 101570622 |
| 20160191 | 20061677 | 1.73 | 59 | Palliative (P) | 2019-05-14 | 2019-05-29 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101482633 |
| 20160192 | 20061678 | 1.69 | 72 | Palliative (P) | 2016-01-22 | 2016-02-13 | ECX | N | N | ECX | 100863961 |